Tamm Horsfall protein binds to a single class of carbohydrate specific receptors on human neutrophils
Lets look at the specifics
Furthermore, GLP-1 RA-related NAEs are likely to occur in the early stages of treatment, mirroring the temporal trajectory of psychiatric 19 , gastrointestinal 36 , and ophthalmic 37 AEs associated with these agents, and emphasizing vigilance during treatment initiation phase
Approval requires documented medical necessity, BMI thresholds (typically 27+ with comorbidities or 30+), and trial of metformin or other diabetes medications
(The most common side effects are gastrointestinal discomfort and nausea.) Eventually, if you keep taking GLP1s, you will reach a plateau
However, a pharmacovigilance study using the WHO's global adverse drug reaction database found disproportionate reporting of eating disorder adverse events with all three major GLP-1 medications ( Nishida et al., Clinical Nutrition, 2025 )